CD34 and acute lymphoblastic leukemia: We tested the ability of Val-ILs to eradicate cancer cells when CD34+ hematopoietic stem cells (HSC) isolated from human cord blood were deliberately contaminated with ~1% of GFP+ B-ALL cells.